[ad_1] An American research study has revealed a hospital Mount Sinai In New York on the success of a drug evinacumab Experimental reduction of low-density lipoprotein cholesterol, or so-called “bad” cholesterol, by 50% in patients with severe hypercholesterolemia, whose condition is resistant to standard treatments, according to a newspaper. TIME …
Read More »Antibody therapy is able to reduce harmful cholesterol by 50%.
